INSULET CORP (PODD) — SEC Filings

Latest SEC filings for INSULET CORP (PODD), explained in plain English.

Sentiment Overview: 1 bullish, 42 neutral, 1 mixed

Recent Filings (44)

• Insulet Corp Changes Independent Auditor — 8-K · 2025-12-19T00:00:00.000Z [neutral] Risk: low
  On December 15, 2025, Insulet Corporation (INSULET) reported a change in its certifying accountant. The company's Audit Committee dismissed PricewaterhouseCoope
• Insulet Corp Reports Director Departure and Officer Compensation Changes — 8-K · 2025-12-17T00:00:00.000Z [neutral] Risk: low
  On December 11, 2025, Insulet Corporation filed an 8-K report detailing the departure of director Robert E. H. Johnson III. The filing also announced the electi
• Insulet's Revenue Soars, Net Income Dips on Debt Extinguishment — 10-Q · 2025-11-06T00:00:00.000Z [mixed] Risk: medium
  Insulet Corporation (PODD) reported robust revenue growth for the nine months ended September 30, 2025, reaching $1,924.3 million, a significant increase from $
• Insulet Corp Reports Director Changes and Compensation Updates — 8-K · 2025-10-23T00:00:00.000Z [neutral] Risk: low
  On October 21, 2025, Insulet Corporation (INS) filed an 8-K report detailing changes in its board of directors and executive compensation. The filing includes t
• Insulet Corp Files 8-K: Director, Officer, and Compensation Updates — 8-K · 2025-09-16T00:00:00.000Z [neutral] Risk: low
  On September 11, 2025, Insulet Corporation filed an 8-K report detailing changes in its board of directors and executive officers, along with updates to compens
• Insulet's Q2 Revenue Jumps 21.8%, Net Income Up 29.6% — 10-Q · 2025-08-07T00:00:00.000Z [bullish] Risk: low
  Insulet Corp (PODD) reported robust financial performance for the second quarter ended June 30, 2025, with significant revenue growth and improved net income. T
• Insulet Corp (PODD) Files 8-K: Agreements and Obligations — 8-K · 2025-06-09T00:00:00.000Z [neutral] Risk: medium
  On June 6, 2025, Insulet Corporation entered into a Material Definitive Agreement and also experienced the Termination of a Material Definitive Agreement. The c
• Insulet Corp Files 8-K on Officer Changes and Shareholder Votes — 8-K · 2025-05-28T00:00:00.000Z [neutral] Risk: low
  On May 22, 2025, Insulet Corporation filed an 8-K report detailing several key events. The filing includes information regarding the departure of directors or c
• Insulet Corp. Files Q1 2025 10-Q — 10-Q · 2025-05-09T00:00:00.000Z [neutral] Risk: medium
  Insulet Corp. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 202
• Insulet Corp Files 8-K on Financials — 8-K · 2025-05-08T00:00:00.000Z [neutral] Risk: low
  On May 8, 2025, Insulet Corporation filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as f
• Insulet Corp Files Definitive Proxy Statement for 2025 Annual Meeting — DEF 14A · 2025-04-29T00:00:00.000Z [neutral] Risk: low
  Insulet Corporation filed its definitive proxy statement (DEF 14A) on April 29, 2025, for its annual meeting on May 22, 2025. The filing details information req
• Insulet Corp. Board Shake-up: New Directors Elected, Two Depart — 8-K · 2025-04-28T00:00:00.000Z [neutral] Risk: medium
  On April 27, 2025, Insulet Corporation filed an 8-K report detailing the departure of two directors, Dr. Robert E. Smith and Ms. Pamela E. Perry, effective Apri
• Insulet Corp Files 8-K/A Amendment — 8-K/A · 2025-04-09T00:00:00.000Z [neutral] Risk: low
  Insulet Corporation filed an amendment (8-K/A) on April 9, 2025, to its previous report dated March 14, 2025. This amendment pertains to the departure of direct
• Insulet Corp Enters Material Definitive Agreement — 8-K · 2025-03-21T00:00:00.000Z [neutral] Risk: medium
  On March 20, 2025, Insulet Corporation entered into a material definitive agreement related to a direct financial obligation. The company, incorporated in Delaw
• Insulet Corp Files 8-K with Exhibits — 8-K · 2025-03-18T00:00:00.000Z [neutral] Risk: low
  On March 18, 2025, Insulet Corporation filed an 8-K report. The filing primarily concerns financial statements and exhibits, and a Regulation FD disclosure. No
• Insulet Corp (PODD) Reports Executive & Director Changes — 8-K · 2025-03-17T00:00:00.000Z [neutral] Risk: medium
  On March 14, 2025, Insulet Corporation filed an 8-K report detailing changes in its executive officers and board of directors. The filing indicates a departure
• Insulet Corp Files 8-K for Material Definitive Agreement — 8-K · 2025-03-10T00:00:00.000Z [neutral] Risk: medium
  On March 7, 2025, Insulet Corporation entered into a material definitive agreement. The filing does not provide specific details about the agreement, its counte
• Insulet Corp Files 2024 10-K — 10-K · 2025-02-21T00:00:00.000Z [neutral] Risk: medium
  Insulet Corporation filed its 2024 10-K on February 21, 2025, reporting its fiscal year ending December 31, 2024. The company, a leader in surgical and medical
• Insulet Corp Files 8-K on Financials — 8-K · 2025-02-20T00:00:00.000Z [neutral] Risk: low
  On February 20, 2025, Insulet Corporation filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as wel
• Insulet Corp Files 8-K — 8-K · 2024-12-04T00:00:00.000Z [neutral] Risk: low
  On December 3, 2024, Insulet Corporation filed an 8-K report to disclose other events and financial statements/exhibits. The filing does not contain specific de
• SC 13G/A Filing — SC 13G/A · 2024-11-12T00:00:00.000Z [neutral]
• Insulet Corp. Files 10-Q for Q3 2024 — 10-Q · 2024-11-08T00:00:00.000Z [neutral] Risk: medium
  Insulet Corp. reported its financial results for the period ending September 30, 2024. The company's filing details its financial position and performance, with
• Insulet Corp Files 8-K on Financials — 8-K · 2024-11-07T00:00:00.000Z [neutral] Risk: low
  On November 7, 2024, Insulet Corporation filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well
• SC 13G/A Filing — SC 13G/A · 2024-10-07T00:00:00.000Z [neutral]
• Insulet Corp. Files 10-Q for Q2 2024 — 10-Q · 2024-08-09T00:00:00.000Z [neutral] Risk: medium
  Insulet Corp. reported its financial results for the period ending June 30, 2024. The company's filing details its financial position and performance, including
• Insulet Corp Files 8-K on Operations and Financials — 8-K · 2024-08-08T00:00:00.000Z [neutral] Risk: low
  On August 8, 2024, Insulet Corporation filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well a
• Insulet Corp Files 8-K on Material Definitive Agreement — 8-K · 2024-08-05T00:00:00.000Z [neutral] Risk: medium
  On August 2, 2024, Insulet Corporation entered into a Material Definitive Agreement related to a direct financial obligation. The company, incorporated in Delaw
• Insulet Corp Files 8-K on Operations and Financials — 8-K · 2024-07-26T00:00:00.000Z [neutral] Risk: low
  On July 26, 2024, Insulet Corporation filed an 8-K report to disclose information regarding its results of operations and financial condition, as well as financ
• Insulet Corp Files 8-K on Security Holder Vote — 8-K · 2024-05-28T00:00:00.000Z [neutral] Risk: low
  On May 22, 2024, Insulet Corporation filed an 8-K report detailing a submission of matters to a vote of security holders. The filing does not contain specific d
• Insulet Corp Files 8-K for Material Definitive Agreement — 8-K · 2024-05-20T00:00:00.000Z [neutral] Risk: medium
  On May 15, 2024, Insulet Corporation entered into a Material Definitive Agreement. The filing does not provide specific details about the agreement or any assoc
• Insulet Corp Files 10-Q for Q1 2024 — 10-Q · 2024-05-10T00:00:00.000Z [neutral] Risk: medium
  Insulet Corporation reported its first quarter 2024 results for the period ending March 31, 2024. The company's filing details its financial position and operat
• Insulet Corp Files 8-K: Financial Update — 8-K · 2024-05-09T00:00:00.000Z [neutral] Risk: low
  On May 9, 2024, Insulet Corporation filed an 8-K report detailing its financial results and operations. The filing includes financial statements and exhibits, p
• Insulet Corp Files 2024 Proxy Statement — DEF 14A · 2024-04-09T00:00:00.000Z [neutral] Risk: low
  Insulet Corporation filed its DEF 14A proxy statement on April 9, 2024, for its annual meeting on May 22, 2024. The filing outlines the information required for
• Insulet Appoints Two New Directors to Board — 8-K · 2024-03-20T00:00:00.000Z [neutral] Risk: low
  On March 20, 2024, Insulet Corporation announced the appointment of two new members to its Board of Directors, Dr. David J. Adair and Ms. Pamela E. Perry. This
• Insulet Corp Files 8-K on Director Changes and Compensation — 8-K · 2024-03-01T00:00:00.000Z [neutral] Risk: low
  On February 26, 2024, Insulet Corporation filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing in
• Insulet Corp Files 2023 10-K, Details Fiscal Year Performance — 10-K · 2024-02-23T00:00:00.000Z [neutral] Risk: medium
  Insulet Corp, a medical device company, filed its 10-K on February 23, 2024, for the fiscal year ending December 31, 2023. The company, based in Acton, MA, oper
• Insulet Files 8-K on Financial Condition and Operations — 8-K · 2024-02-22T00:00:00.000Z [neutral] Risk: low
  Insulet Corporation filed an 8-K on February 22, 2024, to report on its results of operations and financial condition. The filing, under SEC File Number 001-334
• SC 13G/A Filing — SC 13G/A · 2024-02-13T00:00:00.000Z [neutral]
• Capital Research Global Investors Trims Insulet Stake to 14.3% — SC 13G/A · 2024-02-09T00:00:00.000Z [neutral] Risk: low
  Capital Research Global Investors, a major institutional investor, filed an amended SC 13G/A on February 9, 2024, disclosing a slight decrease in its beneficial
• FMR LLC & Abigail Johnson Hold 8.45% Stake in Insulet Corp — SC 13G/A · 2024-02-09T00:00:00.000Z [neutral] Risk: low
  FMR LLC, a major investment firm, and its principal owner, Abigail P. Johnson, have updated their ownership stake in Insulet Corp. As of February 9, 2024, they
• Wellington Management Amends Insulet Corp (PODD) Stake — SC 13G/A · 2024-02-08T00:00:00.000Z [neutral] Risk: low
  Wellington Management Group LLP, a Massachusetts-based investment firm, filed an amended SC 13G/A on February 8, 2024, indicating their ownership of Insulet Cor
• Insulet Corp Enters Material Agreement, Takes on New Financial Obligation — 8-K · 2024-01-25T00:00:00.000Z [neutral]
  Insulet Corporation, a medical device company, filed an 8-K on January 25, 2024, reporting an "Entry into a Material Definitive Agreement" and the "Creation of
• BlackRock Amends Insulet Corp. Stake, Signals Passive Investment — SC 13G/A · 2024-01-25T00:00:00.000Z [neutral]
  BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, indicating its ownership of Insulet Corporation's common stock as of December 31, 2023. This filin
• Insulet 8-K: Officer Changes, Compensation, Reg FD Disclosure — 8-K · 2024-01-18T00:00:00.000Z [neutral]
  Insulet Corporation filed an 8-K on January 18, 2024, to report on the departure of directors or certain officers, election of directors, appointment of certain